Rheumatology

In this Healio video exclusive, Leonard Calabrese, DO, chief medical editor of Healio Rheumatology, discussed the top items from the February issue, including an exploration of how the placebo effect can be applied in rheumatology.

Specialty Networks, LLC, a portfolio company of Linden Capital Partners, has announced the acquisition of United Rheumatology, LLC, according to a company press release.

As we now enter the third year of COVID-19 and reflect, we should begin by asking ourselves: Just how good are we doing in critically appraising and utilizing the emerging science of this new field?

As a college student, I met a young woman, a member of my church, with severe, deforming rheumatoid arthritis. Despite her severe pain and difficulty with daily activities, she had an amazing attitude and provided inspiration for me to want to help people with chronic medical conditions.

The COVID-19 pandemic brought with it a significant decrease in autoimmunity laboratory testing, first rheumatology visits and diagnoses from 2019 to 2020, according to Italian data published in The Journal of Rheumatology.

In the top story in rheumatology last week, new data showed that U.S. active-duty service members with PTSD had much higher rates of fibromyalgia compared with the overall population of service members who were awaiting deployment.

Healio announced the launch of Rheum and Boards, a quiz-based, online learning resource for rheumatologists, according to a Healio press release.

I grew up in South Africa, and my late father was a well-known general practitioner. I used to go along with him on house calls and that was my first hook in medicine, per se. I was drawn into it — and maybe that was his intention.

In this Healio Rheumatology Video Perspective, Leonard Calabrese, DO, shares his personal experience with a breakthrough COVID-19 infection, offering sage advice for clinicians who encounter COVID in their daily lives as well as their daily practice.

The American College of Rheumatology recommended that patients with rheumatic diseases who are on immunosuppressants receive a third dose of an mRNA COVID-19 vaccine. It was the top story in rheumatology last week.